BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 236 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,443,763 | -24.7% | 2,346,934 | 0.0% | 54.70% | +20.7% |
| Q2 2023 | $74,937,603 | +4.3% | 2,346,934 | 0.0% | 45.33% | -10.4% |
| Q1 2023 | $71,863,119 | -21.7% | 2,346,934 | 0.0% | 50.60% | +8.0% |
| Q4 2022 | $91,788,589 | -17.9% | 2,346,934 | 0.0% | 46.86% | +8.8% |
| Q3 2022 | $111,808,000 | +23.1% | 2,346,934 | 0.0% | 43.07% | +5.4% |
| Q2 2022 | $90,850,000 | -32.4% | 2,346,934 | 0.0% | 40.87% | -28.2% |
| Q1 2022 | $134,479,000 | -28.1% | 2,346,934 | 0.0% | 56.91% | +4.4% |
| Q4 2021 | $187,027,000 | -9.0% | 2,346,934 | -0.7% | 54.51% | +118.7% |
| Q3 2021 | $205,573,000 | -32.4% | 2,362,635 | 0.0% | 24.93% | -16.6% |
| Q2 2021 | $304,095,000 | +60.8% | 2,362,635 | 0.0% | 29.88% | -67.5% |
| Q1 2021 | $189,105,000 | +26.9% | 2,362,635 | +129359.5% | 91.90% | -2.7% |
| Q4 2020 | $148,993,000 | – | 1,825 | – | 94.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |